| Biological Therapy in Treating Children With Refractory or Recurrent Neuroblastoma or Other Tumors (NCT00003750) | Children's Oncology Group | 2001-10-01 |
| Eligibility Screening for a NCI Pediatric Oncology Branch Research Study (NCT00026780) | National Cancer Institute (NCI) | 2001-09-24 |
| Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Neuroblastoma (NCT00017368) | Children's Oncology Group | 2001-04-01 |
| Caspofungin Acetate in Treating Children With Fever and Neutropenia (NCT00020527) | National Cancer Institute (NCI) | 2001-03-01 |
| Arsenic Trioxide in Treating Patients With Advanced Neuroblastoma or Other Childhood Solid Tumors (NCT00024258) | Memorial Sloan Kettering Cancer Center | 2001-03-01 |
| Combination Chemotherapy Before Surgery in Treating Children With Localized Neuroblastoma (NCT00025428) | Societe Internationale d'Oncologie Pediatrique | 2000-12-01 |
| Molecular Characterization of Neuroblastic Tumor: Correlation With Clinical Outcome (NCT00588068) | Memorial Sloan Kettering Cancer Center | 2000-09-26 |
| Interleukin-11 Plus Filgrastim Prior to Peripheral Stem Cell Transplantation in Patients With Non-Hodgkin's Lymphoma, Hodgkin's Disease, Breast Cancer, or Other Solid Tumors (NCT00004157) | Fred Hutchinson Cancer Center | 2000-08-01 |
| Temozolomide Plus Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Malignant Glioma or Recurrent CNS or Other Solid Tumors (NCT00005952) | Duke University | 2000-08-01 |
| Temozolomide Followed by Radiation Therapy in Treating Children With Newly Diagnosed Malignant CNS Tumors (NCT00005955) | Duke University | 2000-08-01 |
| Beclomethasone in Treating Patients With Graft-Versus-Host Disease of the Esophagus, Stomach, Small Intestine, or Colon (NCT00010283) | Fred Hutchinson Cancer Center | 2000-07-01 |
| Rebeccamycin Analogue in Treating Children With Solid Tumors or Non-Hodgkin's Lymphoma (NCT00006102) | National Cancer Institute (NCI) | 2000-07-01 |
| Multiple Therapies in Treating Patients With Advanced Neuroblastoma (NCT00040872) | Memorial Sloan Kettering Cancer Center | 2000-06-01 |
| Recombinant Human Thrombopoietin in Children Receiving Ifosfamide, Carboplatin, and Etoposide Chemotherapy (NCT00187109) | St. Jude Children's Research Hospital | 2000-06-01 |
| Temozolomide and O6-benzylguanine in Treating Children With Solid Tumors (NCT00020150) | National Cancer Institute (NCI) | 2000-06-01 |
| Biological Therapy and Gene Therapy in Treating Children With Recurrent or Refractory Neuroblastoma (NCT00006480) | Fred Hutchinson Cancer Center | 2000-05-01 |
| N99-01: Combination Chemotherapy, Radiation Therapy, and Stem Cell Transplantation in Treating Patients With Neuroblastoma (NCT00005978) | New Approaches to Neuroblastoma Therapy Consortium | 2000-05-01 |
| Monoclonal Antibody Therapy Plus Etoposide in Treating Patients With Neuroblastoma (NCT00004110) | Memorial Sloan Kettering Cancer Center | 1999-08-01 |
| Combination Chemotherapy Followed by Surgery and Peripheral Stem Cell or Bone Marrow Transplantation in Treating Infants With Newly Diagnosed Neuroblastoma (NCT00025649) | European Infant Neuroblastoma Study Group - 1999 | 1999-07-01 |
| Combination Chemotherapy in Treating Infants With Newly Diagnosed Neuroblastoma (NCT00025610) | European Infant Neuroblastoma Study Group - 1999 | 1999-07-01 |
| Radiation Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With Primitive Neuroectodermal Tumors (NCT00003846) | Children's Oncology Group | 1999-07-01 |
| Combination Chemotherapy Followed by Surgery in Treating Infants With Newly Diagnosed Neuroblastoma. (NCT00025597) | European Infant Neuroblastoma Study Group - 1999 | 1999-07-01 |
| Combination Chemotherapy Followed by Surgery in Treating Infants With Newly Diagnosed Neuroblastoma (NCT00025623) | European Infant Neuroblastoma Study Group - 1999 | 1999-07-01 |
| Chemotherapy and Surgery Followed by Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Neuroblastoma (NCT00024193) | Children's Cancer and Leukaemia Group | 1999-04-01 |
| Rebeccamycin Analog in Treating Children With Relapsed or Refractory Neuroblastoma (NCT00003737) | Memorial Sloan Kettering Cancer Center | 1999-01-01 |
| Amifostine to Protect From Side Effects of PSCT in Treating Patients With Solid Tumors (NCT00003926) | Masonic Cancer Center, University of Minnesota | 1998-11-01 |
| Gene Modified Allogeneic Neuroblastoma Cells For Treatment of Relapsed/Refractory Neuroblastoma (NCT00186862) | St. Jude Children's Research Hospital | 1998-08-01 |
| Lymphocyte Infusion in Treating Patients With Relapsed Cancer After Bone Marrow or Peripheral Stem Cell Transplantation (NCT00003887) | Fred Hutchinson Cancer Center | 1998-08-01 |
| Chemotherapy, Radiation Therapy, and Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer (NCT00003661) | Roswell Park Cancer Institute | 1998-06-01 |
| Biological Therapy Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Cancer (NCT00003408) | Cancer Treatment Centers of America | 1998-04-01 |
| Fenretinide in Treating Children With Solid Tumors (NCT00003191) | National Cancer Institute (NCI) | 1998-03-01 |
| Carboplatin and Vincristine Plus Radiation Therapy Followed By Adjuvant Chemotherapy in Treating Young Patients With Newly Diagnosed CNS Embryonal Tumors (NCT00003203) | Children's Oncology Group | 1998-03-01 |
| Surgery in Treating Children With Neuroblastoma (NCT00003119) | Children's Oncology Group | 1998-03-01 |
| Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Infants With Malignant Brain or Spinal Cord Tumors (NCT00003141) | Children's Oncology Group | 1998-03-01 |
| Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Primary or Metastatic Brain Tumors (NCT00003461) | Duke University | 1998-02-01 |
| Phase I/II Study of Escalating-Dose Melphalan w/Autologous SCS & Amifostine Cytoprotect (NCT00003425) | University of Kentucky | 1997-12-01 |
| Allogeneic Neuroblastoma Cells for Relapsed/ Refractory Neuroblastoma, CYCHEALL (NCT01713439) | Baylor College of Medicine | 1997-12-01 |
| Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Brain Tumor (NCT00003273) | NYU Langone Health | 1997-11-01 |
| Using Gene Modified Neuroblastoma Cells for the Treatment of Relapsed/Refractory Neuroblastoma (NCT00062855) | Baylor College of Medicine | 1997-11-01 |
| Therapy for Children With Advanced Stage High Risk Neuroblastoma (NCT00186849) | St. Jude Children's Research Hospital | 1997-10-01 |
| Interleukin-12 in Treating Patients With Hematologic Cancers or Solid Tumors (NCT00003107) | Indiana University | 1997-10-01 |
| Peripheral Stem Cell Transplantation Plus Chemotherapy in Treating Patients With Malignant Solid Tumors (NCT00007813) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 1997-05-31 |
| Monoclonal Antibody Therapy in Treating Patients With Leptomeningeal Cancer (NCT00003022) | Memorial Sloan Kettering Cancer Center | 1997-04-01 |
| Interleukin-2 in Treating Children With Stage IV Neuroblastoma Who Have Received Induction Therapy and Peripheral Stem Cell Transplantation (NCT00003743) | St. Anna Kinderkrebsforschung | 1997-03-01 |
| Monoclonal Antibody A1G4 Plus BCG in Treating Patients With Cancer (NCT00003023) | Memorial Sloan Kettering Cancer Center | 1997-03-01 |
| Docetaxel in Treating Children With Recurrent Solid Tumors (NCT00002825) | National Cancer Institute (NCI) | 1997-01-01 |
| Antineoplaston Therapy in Treating Patients With Metastatic, Recurrent, or Refractory Neuroblastoma (NCT00003513) | Burzynski Research Institute | 1996-12-16 |
| Phase I and Pharmacokinetic Trial of Phenylbutyrate Given as a Continuous Infusion in Pediatric Patients With Refractory Malignancy (NCT00001565) | National Cancer Institute (NCI) | 1996-12-01 |
| A Phase II Trial of All-Trans-Retinoic Acid in Combination With Interferon-Alpha 2a in Children With Recurrent Neuroblastoma or Wilms' Tumor (NCT00001509) | National Cancer Institute (NCI) | 1996-07-01 |
| Chemotherapy in Treating Children With Neuroblastoma (NCT00002730) | New Approaches to Neuroblastoma Therapy Consortium | 1996-06-01 |
| Combination Chemotherapy Plus Peripheral Stem Cell Transplantation Followed by Surgery and/or Radiation Therapy in Treating Young Patients With Advanced Neuroblastoma (NCT00002740) | Children's Oncology Group | 1996-05-01 |
| Intensive Chemo-Radiotherapy With Peripheral Blood Progenitor Cell Rescue for Children With Advanced Neuroblastoma and Sarcomas (NCT00165139) | Dana-Farber Cancer Institute | 1996-01-01 |
| Prevalence+Significance of Paraneoplastic Autoantibodies in Many Cancers (NCT00608452) | Memorial Sloan Kettering Cancer Center | 1995-07-01 |
| Combination Chemotherapy or Observation Following Surgery in Treating Infants With Neuroblastoma (NCT00002803) | Children's Hospital Medical Center, Cincinnati | 1995-07-01 |
| Combination Chemotherapy Followed By Surgery With or Without Radiation Therapy in Treating Young Patients With Stage II or Stage III Neuroblastoma (NCT00276731) | Children's Cancer and Leukaemia Group | 1995-03-01 |
| Chemotherapy, Radiation Therapy, Immunotherapy, and Bone Marrow Transplantation in Treating Patients With Neuroblastoma (NCT00002634) | Memorial Sloan Kettering Cancer Center | 1995-02-01 |
| Surgery in Treating Patients With Neuroblastoma (NCT00003122) | Societe Internationale d'Oncologie Pediatrique | 1994-12-01 |
| Monoclonal Antibody Therapy Plus Sargramostin in Treating Patients With Advanced Neuroblastoma (NCT00002560) | Memorial Sloan Kettering Cancer Center | 1994-02-01 |
| New Therapeutic Strategies for Patients With Ewing's Sarcoma Family of Tumors, High Risk Rhabdomyosarcoma, and Neuroblastoma (NCT00001335) | National Cancer Institute (NCI) | 1993-04-01 |
| Combination Chemotherapy Followed by Bone Marrow Transplantation in Treating Patients With Rare Cancer (NCT00002515) | Memorial Sloan Kettering Cancer Center | 1992-10-01 |
| Combination Chemotherapy, Surgery, and Radiation Therapy in Treating Infants With Neuroblastoma (NCT00287950) | Children's Cancer and Leukaemia Group | 1992-09-01 |
| Development of Strategies to Increase Enrollment in Clinical Trials for Children With Cancer (NCT00002485) | Children's Oncology Group | 1992-02-01 |
| Gene Therapy in Treating Children With Refractory or Recurrent Neuroblastoma (NCT00002748) | St. Jude Children's Research Hospital | 1991-12-01 |
| Therapy Based on Stage of Disease and Risk Assessment in Treating Children With Neuroblastoma (NCT00002802) | Children's Hospital Medical Center, Cincinnati | 1990-07-01 |
| Combination Chemotherapy in Treating Children With Neuroblastoma (NCT00003093) | Children's Oncology Group | 1988-03-01 |
| 123I-MIBG Scintigraphy in Patients Being Evaluated for Neuroendocrine Tumors (NCT01373736) | Vancouver Coastal Health | |
| A Compassionate Use/Expanded Access Protocol Using 131I-MIBG Therapy for Patients With Refractory Neuroblastoma and Metastatic Pheochromocytoma (NCT03015844) | Northwell Health | |
| Clinical Studies of Gemcitabine-Oxaliplatin (NCT00407433) | Gustave Roussy, Cancer Campus, Grand Paris | |
| 131-I-MIBG Therapy for Refractory Neuroblastoma, Expanded Access Protocol (NCT01163383) | John Maris | |
| Expanded Access Study of Fenretinide Lym-X-Sorb Plus Ketoconazole in Neuroblastoma (NCT02075177) | South Plains Oncology Consortium | |
| Fecal Microbiota Transplant for Neuroblastoma in a Single Patient (NCT07223606) | ProgenaBiome | |
| Combination Chemotherapy and Surgery With or Without Radiation Therapy in Treating Patients With Stage 2 or Stage 3 Neuroblastoma (NCT00416676) | Children's Cancer and Leukaemia Group | |
| CHP677: I-Metaiodobenzylguanidine (I-MIBG) Therapy for Refractory Neuroblastoma: a Phase II Study (NCT00013806) | National Center for Research Resources (NCRR) | |
| 131I-Labeled MIBG for Refractory Neuroblastoma: A Compassionate Use Protocol (NCT01370330) | Kieuhoa Vo | |
| An Intermediate Expanded Use Trial of DFMO (NCT03581240) | Giselle Sholler | |
| Expanded Access Protocol Using 131I-MIBG Therapy +/- Vorinostat for Refractory Neuroblastoma, Pheochromocytoma, or Paraganglioma (NCT01838187) | Children's Hospital Medical Center, Cincinnati | |
| Expanded Access Protocol for [123I]mIBG for Patients With Known or Suspected Neuroblastoma (NCT00730444) | GE Healthcare | |
| Expanded Access Protocol Using 131I-MIBG (NCT01590680) | Jubilant DraxImage Inc. | |
| Combination Chemotherapy in Treating Infants With Newly Diagnosed Neuroblastoma Who Are Undergoing Surgery With or Without Autologous Bone Marrow or Peripheral Stem Cell Transplant (NCT00417053) | Children's Cancer and Leukaemia Group | |